Paper32636741
Phytochemicals: Potential Lead Molecules for MDR Reversal.
Tinoush B and 2 others. Front Pharmacol, 2020. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Phytochemicals: Potential Lead Molecules for MDR Reversal. Papers, record 32636741. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32636741
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References192
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21562851 | Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein. | Med Oncol | 2012 | https://conductscience.org/library/papers/21562851 | PubMed |
| 2 | 31801248 | Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression. | Molecules | 2019 | https://conductscience.org/library/papers/31801248 | PubMed |
| 3 | 11479219 | Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. | Cancer Res | 2001 | https://conductscience.org/library/papers/11479219 | PubMed |
| 4 | 21262330 | Alkaloids derived from genus Veratrum and Peganum of Mongolian origin as multidrug resistance inhibitors of cancer cells. | Fitoterapia | 2011 | https://conductscience.org/library/papers/21262330 | PubMed |
| 5 | 11358822 | Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. | Cancer Res | 2001 | https://conductscience.org/library/papers/11358822 | PubMed |
| 6 | 22927901 | Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell line. | PLoS One | 2012 | https://conductscience.org/library/papers/22927901 | PubMed |
| 7 | 28801675 | Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer. | Sci Rep | 2017 | https://conductscience.org/library/papers/28801675 | PubMed |
| 8 | 21824448 | Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells. | J Pharm Pharm Sci | 2011 | https://conductscience.org/library/papers/21824448 | PubMed |
| 9 | 21081657 | A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21081657 | PubMed |
| 10 | 19519503 | From nature to drug discovery: the indole scaffold as a 'privileged structure'. | Mini Rev Med Chem | 2009 | https://conductscience.org/library/papers/19519503 | PubMed |
| 11 | 17492365 | Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells. | Pharm Res | 2007 | https://conductscience.org/library/papers/17492365 | PubMed |
| 12 | 16964757 | Aporphine alkaloids and their reversal activity of multidrug resistance (MDR) from the stems and rhizomes of Sinomenium acutum. | Arch Pharm Res | 2006 | https://conductscience.org/library/papers/16964757 | PubMed |
| 13 | 15495829 | [Study on effect of berbamine on multidrug resistance leukemia K562/Adr cells]. | Zhongguo Zhong Xi Yi Jie He Za Zhi | 2004 | https://conductscience.org/library/papers/15495829 | PubMed |
| 14 | 27328029 | Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents. | J Med Chem | 2016 | https://conductscience.org/library/papers/27328029 | PubMed |
| 15 | 17664318 | The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17664318 | PubMed |
| 16 | 23326571 | Purine nucleoside analog--sulfinosine modulates diverse mechanisms of cancer progression in multi-drug resistant cancer cell lines. | PLoS One | 2013 | https://conductscience.org/library/papers/23326571 | PubMed |
| 17 | 7623038 | (-)-Roemerine, an aporphine alkaloid from Annona senegalensis that reverses the multidrug-resistance phenotype with cultured cells. | J Nat Prod | 1995 | https://conductscience.org/library/papers/7623038 | PubMed |
| 18 | 16960658 | Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. | Mol Cell Biochem | 2007 | https://conductscience.org/library/papers/16960658 | PubMed |
| 19 | 10656440 | Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. | Clin Cancer Res | 2000 | https://conductscience.org/library/papers/10656440 | PubMed |
| 20 | 29747752 | Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells. | Phytomedicine | 2018 | https://conductscience.org/library/papers/29747752 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42653730 | Plant-Derived Natural Products and Selective Apoptosis: A Cancer-Cell Vulnerability-State Framework from Redox Imbalance to Membrane-Ion Dysregulation. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653730 | PubMed |
| 42181709 | Curcumin derivatives with 1,5-diaryl-3-oxo-1,4-pentadiene: novel dual-function lead compounds showing anticancer and MDR reversal effects. | RSC Adv | 2026 | https://conductscience.org/library/papers/42181709 | PubMed |
| 42123417 | Combined Anti-Inflammatory Effects of Curcumin and Evodiamine: In Vitro Synergy, Docking, and Molecular Orbital Insights. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123417 | PubMed |
| 41594926 | Medicinal Plants for Overcoming Drug Resistance in Cervical Cancer. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/41594926 | PubMed |
| 40722893 | Mediterranean Diet and Agri-Food By-Products: A Possible Sustainable Approach for Breast Cancer Treatment. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40722893 | PubMed |
| 40696057 | Hispidulin: a potential alternative to vorinostat against HDAC1 for acute myeloid leukemia. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40696057 | PubMed |
| 40649986 | Isorhamnetin Modulates Drug-Resistance-Related Biomarkers in Colon Cancer Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40649986 | PubMed |
| 39886778 | Organosulfur Compounds in Garlic for Gastric Cancer Treatment: Anticancer Effects, Overcoming Drug Resistance, and Mechanisms. | Recent Pat Anticancer Drug Discov | 2025 | https://conductscience.org/library/papers/39886778 | PubMed |
| 39329928 | Modulation of Multidrug Resistance Transporters by Food Components and Dietary Supplements: Implications for Cancer Therapy Efficacy and Safety. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/39329928 | PubMed |
| 39051588 | Reduction-Responsive Polyprodrug Nanoplatform Based on Curcumin for Tumor-Targeted Therapy. | Curr Drug Deliv | 2025 | https://conductscience.org/library/papers/39051588 | PubMed |
| 38730738 | Phytochemical Modulation of Ion Channels in Oncologic Symptomatology and Treatment. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38730738 | PubMed |
| 38706362 | Evaluation of Novel Benzo-annelated 1,4-dihydropyridines as MDR Modulators in Cancer Cells. | Anticancer Agents Med Chem | 2024 | https://conductscience.org/library/papers/38706362 | PubMed |
| 38543147 | Natural Compounds and Breast Cancer: Chemo-Preventive and Therapeutic Capabilities of Chlorogenic Acid and Cinnamaldehyde. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38543147 | PubMed |
| 37842517 | Bioinformatic analysis of highly consumed phytochemicals as P-gp binders to overcome drug-resistance. | Res Pharm Sci | 2023 | https://conductscience.org/library/papers/37842517 | PubMed |
| 37313537 | Bixin and Fuxoxanthin Alone and in Combination with Cisplatin Regulate ABCC1 and ABCC2 Transcription in A549 Lung Cancer Cells. | J Pharm Bioallied Sci | 2023 | https://conductscience.org/library/papers/37313537 | PubMed |
| 37290955 | Curcumin Enhances the Anticancer Effects of Binimetinib on Melanoma Cells by Inducing Mitochondrial Dysfunction and Cell Apoptosis with Necroptosis. | Ann Dermatol | 2023 | https://conductscience.org/library/papers/37290955 | PubMed |
| 37259354 | Pinostrobin and Tectochrysin Conquer Multidrug-Resistant Cancer Cells via Inhibiting P-Glycoprotein ATPase. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37259354 | PubMed |
| 37242430 | Therapeutic Investigation of Palm Oil Mill Effluent-Derived Beta-Carotene in Streptozotocin-Induced Diabetic Retinopathy via the Regulation of Blood-Retina Barrier Functions. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37242430 | PubMed |
| 37205177 | Pterostilbene-isothiocyanate reduces miR-21 level by impeding Dicer-mediated processing of pre-miR-21 in 5-fluorouracil and tamoxifen-resistant human breast cancer cell lines. | 3 Biotech | 2023 | https://conductscience.org/library/papers/37205177 | PubMed |
| 36983038 | Chalcones and Gastrointestinal Cancers: Experimental Evidence. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36983038 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32636741
GET https://conductscience.org/api/papers/v1/32636741/references?page=2